alexa T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis.
Materials Science

Materials Science

Journal of Nanomedicine & Nanotechnology

Author(s): Planck A, Katchar K, Eklund A, Gripenbck S, Grunewald J

Abstract Share this page

Abstract BACKGROUND AND AIMS: CD4+ T-lymphocytes are accumulated at the sites of inflammation in sarcoidosis and assumed to play a key role in directing the immune events. By analysing their expression of activation molecules and comparing it between sarcoidosis patients at disease onset and patients at clinical resolution, our aims were to increase the knowledge of their role and find markers of disease activity. METHODS: Thirty-two sarcoidosis patients, 23 at disease onset and 9 after clinical resolution, and 36 healthy controls were included. All patients were HLA-DR17 positive, a group sharing several clinical and immunological features. CD4+ T-lymphocytes from bronchoalveolar lavage fluid (BALF) and peripheral blood were analysed for the expression of CD25, HLA-DR and CD69 by flow cytometry. RESULTS: The CD25 and HLA-DR expression were increased on CD4+ lymphocytes from BALF and peripheral blood at disease onset compared to patients with clinically resolved disease and controls. Interestingly, the percentage of T regulatory (Treg) cells, defined as CD4+ CD25(bright) lymphocytes, was increased in both BALF and blood from patients with active disease. The CD69 expression did not differ between the groups in either compartment. CONCLUSIONS: CD4+ BALF and blood lymphocytes from DR17 positive patients with active sarcoidosis reveal an increased expression of activity markers compared to patients after clinical resolution. An increased number of Treg cells in active sarcoidosis may be involved in the characteristic down-regulation of cell-mediated immune responses in this disease. The results indicate that analysis of these activation markers could be useful as markers of disease activity in sarcoidosis.
This article was published in Sarcoidosis Vasc Diffuse Lung Dis and referenced in Journal of Nanomedicine & Nanotechnology

Relevant Expert PPTs

Recommended Conferences

  • Nano Congress for Next Generation
    August 31-September 01, 2017 Brussels,Belgium
  • Graphene & 2D Materials
    September 14-15, 2017 Edinburgh, Scotland
  • Graphene & 2D Materials
    November 6-7, 2017 Frankfurt, Germany
  • World Congress on Nanoscience and Nano Technology
    October 16-17, 2017 Dubai, UAE
  • World Medical Nanotechnology Congress
    October 18-19, 2017 Osaka, Japan
  • Nanoscienceand Molecular Nanotechnology
    Nov 06-08, 2017 Frankfurt, Germany
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords